Author: Gauthier C. Langin D. Balligand J.-L.
Publisher: Elsevier
ISSN: 0165-6147
Source: Trends in Pharmacological Sciences, Vol.21, Iss.11, 2000-11, pp. : 426-431
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Involvement of 2 -adrenoceptors in the cardiovascular effects of moxonidine
By Urban R. Szabo B. Starke K.
European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. :
Tools to study β3-adrenoceptors
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 5-6, 2007-02 ,pp. :
Pharmacological criteria for the detection of 3 -adrenoceptors
By De Ponti F.
Trends in Pharmacological Sciences, Vol. 18, Iss. 2, 1997-02 ,pp. :
By Ponti F.D.E. Modini C. Gibelli G. Crema F. Frigo G.
Pharmacological Research, Vol. 39, Iss. 5, 1999-05 ,pp. :
By Ireland L.M. Cain J.C. Rotert G. Thomas S. Shoghi S. Hancock A.A. Kerwin J.F.
European Journal of Pharmacology, Vol. 327, Iss. 1, 1997-05 ,pp. :